Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking

12 Dec 2023

Abstract excerpt

OBJECTIVE: Osteosarcoma is a primary malignancy originating from mesenchymal tissue characterized by rapid growth, early metastasis and poor prognosis. Ginsenoside Rg5 (G-Rg5) is a minor ginsenoside extracted from Panax ginseng C.A. Meyer which has been discovered to possess anti-tumor properties. The objective of current study was to explore the mechanism of G-Rg5 in the treatment of osteosarcoma by network...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ginseng Biological Effects and Applications
Share to Lipid metabolism and disorders
Share to Pharmacological Effects of Natural Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38086608
DOI: 10.1111/os.13971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular DockingPMID 38086608Read ↗

Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection against osteosarcomaSemantic proximity Read ↗

Network pharmacology and molecular docking analysis on potential targets and mechanisms of the active monomer of Huayan Capsules in the treatment of osteosarcomaSemantic proximity Read ↗

Molecular Signaling Pathways as Potential Therapeutic Targets in OsteosarcomaSemantic proximity Read ↗

Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular DockingSemantic proximity Read ↗

Screening key marker molecules of osteosarcoma using bioinformatics analysis technologySemantic proximity Read ↗

Identification of Driver Genes and Key Pathways of Osteosarcoma Shows K-7174 As a Novel Anti-osteosarcoma Drug by Inhibiting VCAM1Semantic proximity Read ↗

Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysisSemantic proximity Read ↗

Predicting the levels of orcinol glucoside during the treatment of osteoporosis by network pharmacology and molecular dockingSemantic proximity Read ↗

COL5A2 Inhibits the TGF-β and Wnt/β-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of OsteosarcomaSemantic proximity Read ↗

Analysis of publicly available transcriptomic data to identify key genes and pathways associated with osteosarcoma metastasisSemantic proximity Read ↗

Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating OsteoporosisSemantic proximity Read ↗

A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.